3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
51
Endometrial Neoplasms
6
Ovarian Neoplasms
5
Neoplasm Metastasis
5
Neoplasms
4
Advanced Breast Cancer
4
Prostatic Neoplasms
3
Polycystic Ovary Syndrome
3
Carcinoma, Intraductal, Noninfiltrating
3
Triple Negative Breast Neoplasms
2
Recurrence
2
Neoplasms by Site
2
HR+/HER2- Breast Cancer
2
Estrogen Receptor-positive Breast Cancer
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms, Male
2
Breast Diseases
2
Uterine Cervical Neoplasms
1
Unilateral Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sexual Dysfunctions, Psychological
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Low-Grade Serous Ovarian Cancer
1
Low Grade Serous Ovarian Carcinoma
1
Low Grade Serous Ovarian Cancer
1
Locoregional Recurrence
1
Leiomyoma
1
Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer
1
Interventions
pembrolizumab
1
Pemetrexed
1
Control Groups
1
Cisplatin
1
Carboplatin
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pathologic Processes
×
Letrozole
×
90 days
×
Clear all
No trials found.